Drug Database
Back to search

Netherlands· NL-b980d9de4394

Diarreeremmer HTP loperamide HCl 2 mg, capsules

A loperamide product containing loperamidehydrochloride, registered in Netherlands by Healthypharm B.V.. The same ATC class is registered in 18 of our 19 countries.

ATC A07DA03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDiarreeremmer HTP loperamide HCl 2 mg…ATCA07DA03REGISTER NO.NL-b980d9de4394PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about loperamidehydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Loperamide is registered in 18 of 19 countries.

Countries holding a registration under ATC A07DA03 (loperamide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose
Search loperamide products by name

Loperamide · ATC A07DA03

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of loperamide costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.55 in France to $2.29 in Switzerland — a ×4.2 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Loperamide · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.29
  • FR France$0.55
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LOPERAMIDEHYDROCHLORIDE
Manufacturer
Healthypharm B.V.
Country
Netherlands (NL)
ATC code
A07DA03
ATC class
Loperamide
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    20642=15140

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

723 interactions on record for loperamide.

Graded by severity as the source publishes them — 48 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check loperamide against other medicinesHow interaction checks work

Loperamide · interactions on record

723 records

  • 48 severe
  • 337 moderate
  • 1 minor
  • 337 info

Most severe, free to view

  • CimetidineA02BA01severe
  • RanitidineA02BA02severe
  • PapaverineA03AD01severe
  • LonafarnibA16AX20severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under A07DA03

Loperamide, as other registers publish it.

All loperamide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4423cfe2-ea9c-40d5-bb5b-729ea2708091
GET /v1/drugs/4423cfe2-ea9c-40d5-bb5b-729ea2708091?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h15140_smpc.pdf",
  "strength": null,
  "atc_label": "Loperamide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg20642",
  "excipients": [
    "CHINOLINEGEEL (E 104)",
    "GELATINE (E 441)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "INDIGOKARMIJN (E 132)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "LOPERAMIDEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h20642.pdf",
  "authorised_at": "1997/01/07",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend apotheek of drogist$SEMICOLON$ Algemene verkoop [conform voorwaarden CBG AV-lijst d.d. 6 september 2007]",
  "registration_number": "20642=15140",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about loperamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console